Bimbingamba Zerosix Third Phase: Studying Communities
Launched by AZIENDA OSPEDALIERO UNIVERSITARIA MAGGIORE DELLA CARITA · May 5, 2023
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
The Bimbingamba Zerosix Third Phase trial is focused on helping young children, specifically those aged 0 to 7 years, and their families prevent obesity and promote healthier lifestyles. Childhood obesity is a growing concern, especially in developed countries, and it can lead to serious health problems later in life. This trial aims to create and test community-based programs designed to encourage healthier habits in children and improve their overall well-being.
To participate, children must be between 0 to 5 years old and live in the municipalities of Mondovì or Savigliano. The study will include around 2000 children, with about 1000 from each location. Families can expect to be involved in various community activities aimed at improving nutrition and physical activity. This is a great opportunity for families to contribute to important research that could make a significant difference in the fight against childhood obesity.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children aged 0-5 year of both sex resident in the two Municipalities under evaluation
- • children having date of birth between 1/1/2018 and 31/12/2022 (subjects born 5 years prior to the start of the project)
- • newborns between 01/1/2023 and 21/6/2023 residing in the two municipalities under study.
- Exclusion Criteria:
- • Residence/domicile in the municipalities under investigation, for a period of time less than 6 months following recruitment;
- • Recruitment of the child in other intervention trials of any nature.
About Azienda Ospedaliero Universitaria Maggiore Della Carita
Azienda Ospedaliero Universitaria Maggiore della Carità is a leading academic hospital in Italy, renowned for its commitment to advancing healthcare through innovative clinical research and comprehensive patient care. With a focus on a wide range of medical specialties, the institution collaborates with various research entities to conduct rigorous clinical trials aimed at improving treatment outcomes and enhancing medical knowledge. Its state-of-the-art facilities and multidisciplinary approach ensure high-quality standards in research, fostering an environment conducive to scientific discovery and the development of new therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Novara, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported